Baker Bros. Advisors »

Denali Therapeutics shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $56M 2.6M 21.46
2023-09-30 $47M 2.3M 20.63
2023-06-30 $43M 1.5M 29.51
2023-03-31 $25M 1.1M 23.04
2022-12-31 $30M 1.1M 27.81
2022-09-30 $18M 589k 30.69
2022-06-30 $17M 589k 29.43
2022-03-31 $2.9M 89k 32.17
2021-12-31 $4.0M 89k 44.60
2021-09-30 $4.5M 89k 50.45
2021-06-30 $7.0M 89k 78.44
2021-03-31 $5.1M 89k 57.10
2020-12-31 $7.4M 89k 83.76
2020-09-30 $3.6M 99k 35.84
2020-06-30 $2.5M 105k 24.18
2020-03-31 $1.8M 105k 17.51